We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
-2.54%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$5.55B
AUM Growth
-$172M
Cap. Flow
+$97.5M
Cap. Flow %
1.76%
Top 10 Hldgs %
18.08%
Holding
1,627
New
142
Increased
661
Reduced
568
Closed
164

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$12.9M
2
SGOL icon
abrdn Physical Gold Shares ETF
SGOL
+$12.4M
3
TIPX icon
State Street SPDR Bloomberg 1-10 Year TIPS ETF
TIPX
+$12.2M
4
MSFT icon
Microsoft
MSFT
+$10.1M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$8.73M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$18M
2
SHV icon
iShares 0-1 Year Treasury Bond ETF
SHV
+$17.6M
3
XLNX
Xilinx Inc
XLNX
+$7.92M
4
GTO icon
Invesco Total Return Bond ETF
GTO
+$7.49M
5
SHY icon
iShares 1-3 Year Treasury Bond ETF
SHY
+$7.46M

Sector Composition

Rank Sector Weight
1 Technology 17.91%
2 Financials 11.7%
3 Healthcare 10.28%
4 Industrials 8.25%
5 Consumer Discretionary 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EVN
1376
Eaton Vance Municipal Income Trust
EVN
$416M
$171K ﹤0.01%
14,412
-1,637
-10% -$20.6K
GDO
1377
Western Asset Global Corporate Defined Opportunity Fund
GDO
$77.1M
$170K ﹤0.01%
11,460
– –
IOVA icon
1378
Iovance Biotherapeutics
IOVA
$2.09B
$170K ﹤0.01%
10,196
-1,671
-14% -$25.8K
ACHV icon
1379
Achieve Life Sciences
ACHV
$647M
$169K ﹤0.01%
22,300
-2,500
-10% -$18.6K
MWA icon
1380
Mueller Water Products
MWA
$3.9B
$168K ﹤0.01%
12,978
-29,001
-69% -$374K
VBIV
1381
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$166K ﹤0.01%
3,347
+930
+38% +$46K
IVH
1382
DELISTED
Delaware Ivy High Income Opportunities Fund
IVH
$166K ﹤0.01%
13,100
– –
NID
1383
DELISTED
NUVEEN INTERMEDIATE DURATION MUNICIPAL TERM FUND
NID
$164K ﹤0.01%
11,831
– –
MUA icon
1384
BlackRock MuniAssets Fund
MUA
$512M
$162K ﹤0.01%
12,635
-1,383
-10% -$19K
RIGL icon
1385
Rigel Pharmaceuticals
RIGL
$704M
$159K ﹤0.01%
5,324
-356
-6% -$9.64K
ATXS
1386
DELISTED
Astria Therapeutics
ATXS
$158K ﹤0.01%
23,616
+1,800
+8% +$10.7K
PTY icon
1387
PIMCO Corporate & Income Opportunity Fund
PTY
$2.49B
$158K ﹤0.01%
10,281
-6,199
-38% -$95.4K
PDSB icon
1388
PDS Biotechnology
PDSB
$39.1M
$155K ﹤0.01%
25,000
+11,000
+79% +$68.3K
CGC
1389
Canopy Growth
CGC
$388M
$154K ﹤0.01%
2,030
+708
+54% +$54K
TVRD
1390
Tvardi Therapeutics
TVRD
$19.7M
$152K ﹤0.01%
347
-30
-8% -$12.3K
AMPS
1391
DELISTED
Altus Power
AMPS
$149K ﹤0.01%
20,000
+5,000
+33% +$39.3K
CHW
1392
Calamos Global Dynamic Income Fund
CHW
$523M
$148K ﹤0.01%
16,697
+446
+3% +$4.04K
CRNT icon
1393
Ceragon Networks
CRNT
$197M
$146K ﹤0.01%
68,500
– –
IDE
1394
Voya Infrastructure, Industrials and Materials Fund
IDE
$196M
$145K ﹤0.01%
12,500
+1,000
+9% +$11.3K
NNY icon
1395
Nuveen New York Municipal Value Fund
NNY
$156M
$145K ﹤0.01%
16,000
– –
WIW
1396
Western Asset Inflation-Linked Opportunities & Income Fund
WIW
$507M
$142K ﹤0.01%
11,800
– –
ESRT icon
1397
Empire State Realty Trust
ESRT
$862M
$141K ﹤0.01%
+14,355
New +$135K
HIO
1398
Western Asset High Income Opportunity Fund
HIO
$334M
$141K ﹤0.01%
31,527
-3
-0% -$14
ALLO icon
1399
Allogene Therapeutics
ALLO
$680M
$137K ﹤0.01%
15,050
+3,000
+25% +$31.2K
WEAT icon
1400
Teucrium Wheat Fund
WEAT
$294M
$137K ﹤0.01%
+2,774
New +$120K
54 55
56
57 58

Similar funds

LGF
LGT Group Foundation Vaduz, Liechtenstein $8.19B AUM 27.7% 1-Year Est. Return
CCM
Causeway Capital Management Los Angeles, California $8.15B AUM 29.28% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $8.15B AUM 20.12% 1-Year Est. Return
WJWM
Williams Jones Wealth Management New York $8.14B AUM 19.32% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return
AIM
Allen Investment Management New York $8.09B AUM 16.78% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Oppenheimer & Co's Q1 2022 Portfolio in Review

As of Q1 2022, Oppenheimer & Co held 1,627 positions worth $5.55B, down 3% from $5.72B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Oppenheimer & Co's Q1 2022 filing shows 142 new, 661 increased, 568 reduced and 164 closed positions. Its largest new stake was abrdn Physical Gold Shares ETF: 689,377 shares worth $12.8M. The largest sale was Apple, an estimated $18M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

  • Oppenheimer & Co's largest Q1 2022 buy was abrdn Physical Gold Shares ETF: 689,377 shares worth $12.8M.
  • Oppenheimer & Co added most to Citigroup in Q1 2022, an estimated $12.9M increase.
  • Oppenheimer & Co's biggest Q1 2022 reduction was Apple, cutting an estimated $18M.
  • Oppenheimer & Co fully exited Xilinx Inc in Q1 2022, selling an estimated $7.92M.
  • Oppenheimer & Co's ten largest holdings make up 18% of its $5.55B portfolio in Q1 2022.
  • Oppenheimer & Co opened 142 new positions and closed 164 in Q1 2022.
  • Oppenheimer & Co's portfolio value fell 3% quarter-over-quarter to $5.55B.

Based on Oppenheimer & Co's 13F filing for Q1 2022, filed 12 May 2022.